Form 4 Tracker
Kymera Therapeutics, Inc.
KYMR

24 insider filings · Latest: May 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 3, 2025Mar 3 11:00 PMChiniara Ellen
Proposed Sale
2,241$31.35$70.3K

View →

Mar 3, 2025Mar 3 11:00 PMGollob Jared
Proposed Sale
5,740$31.35$179.9K

View →

Mar 3, 2025Mar 3 11:00 PMJacobs Bruce N.
Proposed Sale
7,035$31.35$220.5K

View →

Jan 6, 2025Jan 6 9:30 PMChiniara Ellen
Proposed Sale
3,129$41.59$130.1K

View →

Dec 2, 2024Dec 2 9:41 PMPAMELA ESPOSITO
Proposed Sale
2,500$46.85$117.1K

View →

Sep 17, 2024Sep 17 8:40 PMPAMELA ESPOSITO
Proposed Sale
13,500$48.48$654.5K

View →

Aug 26, 2024Aug 26 8:32 PMJOANNA HOROBIN
Proposed Sale
12,000$49.16$589.9K

View →

Aug 26, 2024Aug 26 8:25 PMJEFFREY ALBERS
Proposed Sale
5,000$47.78$238.9K

View →

← Previous

Page 5 of 5

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 2, 2026Mar 4 11:00 PMJared GollobChief Medical Officer
Grant/Award
35,300$90.1035,300(D)

View →

Mar 2, 2026Mar 4 11:00 PMBruce N. JacobsChief Financial Officer
Grant/Award
35,300$90.1035,300(D)

View →

Mar 2, 2026Mar 4 11:00 PMNello MainolfiDirector, Chief Executive Officer
Grant/Award
215,000$90.10215,000(D)

View →

Feb 25, 2026Feb 25 10:24 PMNello MainolfiDirector, Chief Executive Officer
Option Exercise
30,000$2.08245,559(D)

View →

Feb 20, 2026Feb 20 10:30 PMPamela EspositoDirector
Option Exercise
2,500$49.102,500(D)

View →

Jan 20, 2026Jan 20 11:30 PMPamela EspositoDirector
Option Exercise
5,500$49.105,000(D)

View →

Dec 31, 2025Dec 31 10:23 PMNello MainolfiDirector, Chief Executive Officer
Option Exercise
30,000$2.08275,559(D)

View →

← Previous

Page 2 of 2